题名 | Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis |
作者 | Ma, Jing1,2; Chen, Yutong3; Li, Tao1,2; Cao, Yi1,2; Hu, Bin1,2; Liu, Yuru1,2; Zhang, Youran1,2; Li, Xiaoyan1,2; Liu, Jianing1,2; Zhang, Wei1,2; Niu, Hanjing1,2; Gao, Jinhua1,2; Zhang, Zhongze1,2; Yue, Kexin1,2; Wang, Jiajia2 ![]() ![]() ![]() |
通讯作者 | Wang, Jiajia; Xie, Songqiang |
发表日期 | 2024-06-14
|
DOI | |
发表期刊 | |
ISSN | 0950-9232
|
EISSN | 1476-5594
|
卷号 | 43期号:25 |
摘要 | Regulatory T cells (Tregs) prevent autoimmunity and contribute to cancer progression. They exert contact-dependent inhibition of immune cells through the production of active transforming growth factor-beta 1 (TGF-beta 1). However, the absence of a specific surface marker makes inhibiting the production of active TGF-beta 1 to specifically deplete human Tregs but not other cell types a challenge. TGF-beta 1 in an inactive form binds to Tregs membrane protein Glycoprotein A Repetitions Predominant (GARP) and then activates it via an unknown mechanism. Here, we demonstrated that tumour necrosis factor receptor-associated factor 3 interacting protein 3 (TRAF3IP3) in the Treg lysosome is involved in this activation mechanism. Using a novel naphthalenelactam-platinum-based anticancer drug (NPt), we developed a new synergistic effect by suppressing ATP-binding cassette subfamily B member 9 (ABCB9) and TRAF3IP3-mediated divergent lysosomal metabolic programs in tumors and human Tregs to block the production of active GARP/TGF-beta 1 for remodeling the tumor microenvironment. Mechanistically, NPt is stored in Treg lysosome to inhibit TRAF3IP3-meditated GARP/TGF-beta 1 complex activation to specifically deplete Tregs. In addition, by promoting the expression of ABCB9 in lysosome membrane, NPt inhibits SARA/p-SMAD2/3 through CHRD-induced TGF-beta 1 signaling pathway. In addition to expose a previously undefined divergent lysosomal metabolic program-meditated GARP/TGF-beta 1 complex blockade by exploring the inherent metabolic plasticity, NPt may serve as a therapeutic tool to boost unrecognized Treg-based immune responses to infection or cancer via a mechanism distinct from traditional platinum drugs and currently available immune-modulatory antibodies. |
相关链接 | [来源记录] |
收录类别 | |
语种 | 英语
|
学校署名 | 其他
|
资助项目 | Second batch of provincial science and technology research and development plan joint funds[225200810116]
; China Postdoctoral Foundation[2023T160190]
; China Postdoctoral Science Foundation[2021M701089]
; Key Scientific Research Projects in Henan Colleges and Universities[22A350002]
; Natural Science Foundation of Henan Province[232300420047]
; Key scientific research projects of universities in Henan province["222102310402","222102310216"]
; Key Program "New Drug Creation" of Guangdong Key Research, Development Plan[2019B020202001]
|
WOS研究方向 | Biochemistry & Molecular Biology
; Oncology
; Cell Biology
; Genetics & Heredity
|
WOS类目 | Biochemistry & Molecular Biology
; Oncology
; Cell Biology
; Genetics & Heredity
|
WOS记录号 | WOS:001217015200001
|
出版者 | |
ESI学科分类 | MOLECULAR BIOLOGY & GENETICS
|
来源库 | Web of Science
|
引用统计 |
被引频次[WOS]:1
|
成果类型 | 期刊论文 |
条目标识符 | http://sustech.caswiz.com/handle/2SGJ60CL/788490 |
专题 | 南方科技大学医学院 |
作者单位 | 1.Henan Univ, Huaihe Hosp Henan Univ, Acad Adv Interdisciplinary Studies, Sch Pharm,Inst Chem Biol,State Key Lab Antiviral D, Kaifeng 475004, Henan, Peoples R China 2.Henan Univ, Joint Natl Lab Antibody Drug Engn, Kaifeng 475004, Henan, Peoples R China 3.South China Univ Technol, Guangzhou 511442, Guangdong, Peoples R China 4.Univ Technol Sydney, Inst Biomed Mat & Devices IBMD, Fac Sci, Sydney, NSW, Australia 5.Henan Univ, Key Lab Nat Med & Immuno Engn, Kaifeng 475004, Peoples R China 6.Southern Univ Sci & Technol, Sch Med, Shenzhen 518005, Guangdong, Peoples R China 7.Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangdong Key Lab Chiral Mol & Drug Discovery, Guangzhou 510006, Peoples R China |
推荐引用方式 GB/T 7714 |
Ma, Jing,Chen, Yutong,Li, Tao,et al. Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis[J]. ONCOGENE,2024,43(25).
|
APA |
Ma, Jing.,Chen, Yutong.,Li, Tao.,Cao, Yi.,Hu, Bin.,...&Xie, Songqiang.(2024).Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis.ONCOGENE,43(25).
|
MLA |
Ma, Jing,et al."Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis".ONCOGENE 43.25(2024).
|
条目包含的文件 | 条目无相关文件。 |
|
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论